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The Efficacy and Safety of Radiofrequency
Microneedling Versus a Nonablative Fractional
1,550-nm Erbium:Glass Laser for the Rejuvenation of
the Neck
Rawaa Almukhtar, MD, MPH,* Emily Wood, MD,† Mitchel Goldman, MD,‡ Sabrina G. Fabi, MD,‡ and Monica Boen, MD‡

BACKGROUND Radiofrequency microneedling (RFMN) and nonablative fractional 1,550-nm erbium:glass lasers (NAFLs)
have been reported to be used with success in neck rejuvenation. There are no head-to-head trials to compare these
modalities.
OBJECTIVE The purpose of the study was to compare the efficacy and safety of radiofrequency microneedling and
nonablative fractional 1,550-nm erbium:glass lasers for the rejuvenation of the neck.
METHODS This was a single-center, randomized, investigator-blinded clinical trial. A total of 21 subjects were randomized
into 2 groups, NAFL and RFMN; subjects received 3 treatments 4 weeks apart and were followed up 12 weeks after last
treatment.
RESULTS Subjects in NAFL and RFMN groups showed 42.1% and 8.6% improvement in the Fitzpatrick–Goldman
Wrinkling Score, respectively, 41.3% and 16.3% improvement in the elastosis score, respectively. Subjects in the NAFL
1,550-nm erbium:glass group showed significantly better blinded investigator Fitzpatrick–Goldman Wrinkling and Elastosis
scores; subjects in the RFMN groups showed a more significant reduction in the Horizontal Neck Wrinkle Severity Score.
There was a trend for higher patient satisfaction with the NAFL.
CONCLUSION This study showed that both treatments resulted in significant improvement in wrinkling and elastosis
scores; the NAFL treatment was associated with significantly better blinded investigator Fitzpatrick–Goldman Wrinkling
and Elastosis scores and better subject satisfaction.

N

eck rejuvenation is a common presenting concern
from patients seeking aesthetic treatments.1 Patients often seek improvement in texture, wrinkling, and laxity of the neck area.1 Treatment of neck skin
needs to take into account the unique anatomical features of
this region, including generally thinner skin, greater laxity,
and fewer pilosebaceous units, resulting in slower healing
and a necessity for increased caution.2–5
Although a traditional surgical neck lift can have
excellent results, it can leave behind unsightly scars and it
does not address major contributing factors such as
photodamage and intrinsic aging.6 Aged skin demonstrates
fragmented dermal collagen that leads to fibroblast
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dysregulation and a decrease in the production of new
collagen.7 This decrease in collagen is seen clinically as
rhytides and laxity. Several nonsurgical modalities have
been developed that stimulate collagen remodeling and
neocollagenesis. Radiofrequency microneedling (RFMN) is
a minimally invasive treatment that creates perforations in
the epidermis and delivers radiofrequency-generated thermal energy (RF) into the underlying dermis to stimulate
neocollagenesis.8 The mechanical effects of microneedles on
the skin promote secretion of growth factors to stimulate
migration and proliferation of adjacent keratinocytes and
fibroblast for skin remodeling.8
The introduction of fractional photothermolysis (FP) in
2004 represents a landmark development in modern laser
technology.9 Fractional photothermolysis generates an
array of microscopic areas of thermal injury in the skin.
These zones of thermal injury induce focal dermal wounds
while sparing the surrounding tissue.9 This allows for fast
healing, minimal adverse events, and minimal down time.10
Nonablative fractional lasers use midinfrared wavelengths
and target water as a chromophore; in this laser technology,
the laser penetrates deep into the midreticular dermis to
induce neocollagenesis and remodeling. The major advantage is the preservation of an intact epidermis with minimal
disruption of the dermal–epidermal junction (DEJ), which
translates to shorter and milder adverse effects.11 The
www.dermatologicsurgery.org
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fractional 1,550-nm erbium laser system (Fraxel re:store
laser system, Solta Medical, Inc., Bothell, WA) was cleared
by the FDA in 2005 for general skin resurfacing. A recent
consensus group on the role of second-generation 1,550-nm
erbium-doped lasers in laser surgery recommended 8 passes
with fluences of 10 to 40 mJ, corresponding to a depth of
555 to 1,120 mm when treating the skin of the neck.12,13
Fitzpatrick skin Types I to III should be treated using a
treatment level of 7 to 11, whereas a treatment level of 4 to 7
is advised in skin Types IV to VI.
Few studies have been published regarding RFMN and
nonablative fractional laser (NAFL) on the neck for
rejuvenation.1,13,14 In addition, there are no head-to-head
trials of these 2 modalities. This study directly compares
RFMN to NAFL for skin restoration on the neck.

Materials and Methods
This was a single-center, prospective, randomized,
investigator-blinded, open-label, institutional review board–
approved clinical trial that was conducted in accordance with
the Declaration of Helsinki and the International Conference
on Harmonization.
After obtaining informed consent, 21 subjects aged 18 to 65
years with a mild to moderate amount of neck wrinkling and
laxity, per the Fitzpatrick–Goldman Classification of Wrinkling and Degree of Elastosis Scale, were enrolled in the study.
Subjects were excluded if they were pregnant or
breastfeeding; had an energy-based device treatment of
the neck area within the previous 6 months; had an
injectable soft tissue filler in the treatment area within the
previous 12 months; had injectable neuromodulator
treatment in the area within the previous 6 months; had a
facial peel or microdermabrasion within the previous 4
weeks; used topical retinoids, hydroquinone, imiquimod,
ingenol mebutate, concentrated hydrogen peroxide, or
diclofenac to the neck within the previous 2 weeks; subjects
on systemic or topical steroids; and those who had a skin
condition involving the neck area that would interfere with
the assessments for this study.

Intervention
A total of 21 female subjects were randomized into 2
groups: the NAFL 1,550-nm erbium:glass (Figure 1) and the
RFMN group (Figure 2). Subjects in both groups received 3
treatments 4 weeks apart. Before each treatment, the neck
was cleansed with isopropyl alcohol, a thin layer of
compounded 23% lidocaine and 7% tetracaine was applied
for 60 minutes to the treatment area. Immediately before
treatment, the anesthetic was wiped off and the neck was
cleansed again with isopropyl alcohol. The nonablative
fractional 1,550-nm erbium:glass laser group was treated
with 8 passes using a fluence of 25 to 35 mJ and a treatment
Level 6 and 7 (17%, 23% coverage), and an average of 2.5
kJ. The RFMN group was treated with 3 passes using the
INTRAcel device (Jeisys, South Korea) at depths 1.5 mm,
0.8 mm, and 0.5 mm, at a treatment Level 5, on a bipolar
setting. Of the note, the device contains 49 insulated
microneedles per cm2. Dynamic cooling was applied during
938
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both treatments. A gentle moisturizer (Vanicream) was
applied immediately after treatment in both groups. Patients
were instructed to use a gentle cleanser (Cetaphil Gentle
Skin Cleanser), apply a physical sunscreen with SPF 30 or
greater, and a gentle moisturizer after treatments. Subjects
were followed up at 4 weeks (Day 90) and 12 weeks (Day
150) after the third treatment.
Subjects were assessed using the Fitzpatrick–Goldman
Classification of Wrinkling and Degree of Elastosis Scale. A
blinded investigator assessed percent improvement of
wrinkles at Day 90 and Day 150. Investigators assessed
side effects and a Global Aesthetic Improvement Scale (1 5
much improved, 2 5 improves, 3 5 no change, 4 5 worse,
and 5 5 much worse) and subject satisfaction (1 5
extremely satisfied, 2 5 satisfied, 3 5 slightly satisfied, 4
5 slightly dissatisfied, 5 5 dissatisfied, and 6 5 extremely
dissatisfied) at each visit after the first treatment. Furthermore, Horizontal Neck Wrinkle Severity Scores were
assessed at each visit using a 5-grade scale (0 5 absent to
minimal, 1 5 mild, 2 5 moderate, 3 5 severe, and 4 5 very
severe). Standardized 2D and Vectra 3D digital photography (Canfield Scientific in Parsippany, NJ) were performed
at each visit.

Statistical Analyses
All statistical tests were 2-sided and interpreted at a 5%
significance level. Descriptive statistics (i.e., mean, SD, etc.)
were provided for all continuous variables and frequencies
for all categorical variables. To track changes for individual
variables across all relevant visits, single-factor analysis of
variance tests were used, whereas comparisons between 2
individual visits were performed using 2-sample t-tests
assuming equal variance. A p-value ,0.05 was considered
clinically significant.

Results
Of the 21 female subjects enrolled in the trial, 2 subjects
were lost to follow-up (1 in the NAFL group and 1 in the
RFMN group), mean age was 49.7 (67.4; age range 37–60)
years. One subject was of Fitzpatrick skin Type I, 15
subjects were of Fitzpatrick skin Type II, 4 subjects were of
Fitzpatrick skin Type III, and 1 subject was of Fitzpatrick
skin Type IV.
Subjects in the NAFL group and the RFMN group
showed 42.1% and 8.6% improvement in the blinded
investigator-assessed Fitzpatrick–Goldman Wrinkling
Score, respectively. Similarly, subjects in the NAFL group
and the RFMN group showed a significant improvement in
the blinded investigator-assessed Fitzpatrick–Goldman
Elastosis Score, corresponding to 41.3% and 16.3%,
respectively (See Supplemental Digital Content, Table S1,
http://links.lww.com/DSS/B93).
At Day 150, subjects in the NAFL group showed
significantly better blinded investigator Fitzpatrick–Goldman
Wrinkling scores when compared with the RFMN group
(scores of 1.00 6 0 and 1.63 6 0.52, respectively; p , .01)
(Figure 3). Similarly, the NAFL group showed significantly
better blinded investigator Fitzpatrick–Goldman Elastosis
www.dermatologicsurgery.org
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Figure 1. Frontal (A) and oblique (B) views of
a subject who received nonablative 1,550-nm
erbium:glass laser treatment to the neck at
baseline, Day 90, and Day 150.

scores when compared with the RFMN group (scores of 2.40
6 0.69 and 3.63 6 1.51, respectively; p 5 .03 and 0.04)
(Figure 4).
Although both the NAFL and RFMN groups resulted in
reduction of the Horizontal Neck Wrinkle Severity Score
(28% and 38%, respectively), only subjects in the RFMNtreated group showed a statistically significant decrease in
the score (p 5 .02) from screening to Day 150.
At Day 60, subjects treated with NAFL showed
significantly higher blinded investigator-assessed Global

Aesthetic Improvement Scale Scores (GAISs) (p 5 .03).
According to the investigator GAIS assessed at Day 150,
44% of subjects in the NAFL group were found to have
26% to 50% improvement and 29% of subjects in the
RFMN group were found to have 26% to 50% improvement (Figure 5).
For adverse events, RFMN showed significantly higher
scores in contour regularity (assessed immediately after
treatment) at Days 30 and 60 only (p , .01) and erythema
(assessed immediately after treatment) at days 1, 30, and 60

Figure 2. Frontal (A) and oblique (B) views of
a subject who received radiofrequency
microneedling treatment to the neck at
baseline, Day 90, and Day 150.
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Figure 3. Blinded investigator-assessed
Fitzpatrick–Goldman Wrinkling Score for
nonablative 1,550-nm erbium:glass laser and
radiofrequency microneedling treatment
groups.

(p , .01, p , .01, and p 5 .02, respectively). Side effects
were short lasting and self-limited. No adverse effects were
reported at Days 90 or 150.
Patient satisfaction was high for both groups; there was a
trend for higher patient satisfaction with NAFL (4.2/5) than
RFMN (3.5/5).

Discussion
There are a wide variety of cosmetic procedures available
for rejuvenation of the neck.15 Two commonly used
modalities in rejuvenation of the neck region are NAFL
and RFMN. This is the first clinical trial to compare the 2
modalities for rejuvenation of the neck area.
We found that subjects in the NAFL group had significantly
better blinded investigator Fitzpatrick–Goldman Wrinkling
and Elastosis scores and better subject satisfaction when
compared with the RFMN group at Day 150. However, when
Horizontal Neck Wrinkle Severity Scores were assessed,
RFMN resulted in a significant decrease corresponding to
38% versus 28% in the NAFL group.
In this study, the NAFL group had 42.1% and 41.3%
improvement in the Fitzpatrick–Goldman Wrinkling and
Elastosis scores, respectively. Few previous studies that

investigated NAFLs have found comparable results. Wanner and colleagues 16 conducted a study investigating the
Nonablative fractional laser (1,550-nm erbium:glass) for
the treatment of facial and nonfacial cutaneous photodamage in 20 subjects with 3 treatments at 3- to 4-week
interval. A 51% to 75% improvement was achieved in 55%
of patient treated on the neck and chest area at 9-month
follow-up. Bencini and colleagues 13 performed a prospective study for neck resurfacing using a 1,540-nm
erbium:glass laser in 18 women with aged neck skin.
Subjects received 6 treatments at 4-week interval and had
significant improvement of 31.7% of wrinkles but not
laxity.
In this study, the RFMN group had 8.6% and 16.3%
improvement in the Fitzpatrick–Goldman Wrinkling and
Elastosis scores, respectively. Few previous studies investigated the use of RFMN in the treatment of neck
laxity.17–20 One international multicenter study from the
United States and Japan investigated use of a RFMN device
containing 25 noninsulated microneedle electrodes to the
face and neck area in 49 patients who received 3 monthly
treatments.17 The neck area was treated with depths of 1.3 to
2.5 mm. Improvement in Fitzpatrick–Goldman Wrinkling

Figure 4. Blinded investigator-assessed
Fitzpatrick–Goldman Elastosis Score for
nonablative 1,550-nm erbium:glass laser and
radiofrequency microneedling treatment
groups.
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Figure 5. Blinded investigator Global Aesthetic Improvement Scores at Day 150.

and Elastosis Scales was seen in 100% of the patients; 65% of
patients had significant improvement in GAIS scores. One
study that compared 3 monthly sessions of RFMN versus
NAFL (1,550-nm erbium:glass) for treatment of atrophic
facial acne scars found results comparable to this study.21
The authors included 20 subjects in each group and found
more improvement of scar severity in the NAFL groups
(25%) than the RFMN group (18.6%).
Fisher and colleagues22 investigated short-term adverse
events associated with the second-generation 1,550-nm
erbium-doped fractionated laser to treat photoaging of the
face, neck, chest, and hands. Side effects were transient and
limited to edema, erythema, dryness, pruritus, bronzing,
and acneiform eruption. A larger study by Graber and
colleagues23 compiled adverse event rates in 961 patients
with Fitzpatrick skin Types I to V undergoing treatments
with a 1,550-nm fractionated erbium-doped laser to the
face, neck, chest, and hands for rejuvenation of sun-damaged
skin. The overall adverse event rate for all sites was 7.6%,
including erosions, herpetic reactivation, secondary bacterial
impetiginization, edema lasting longer than 48 hours, and
acneiform eruptions. Post inflammatory hyperpigmentation
(PIH) occurred in 0.73% of subject and was seen in skin
Types II to V. One study investigating RFMN reported 2
incidences of punctate atrophy.20 Most studies reported side
effects limited to transient erythema and edema.17,18
Limitations to this study included small sample size, the
COVID-19 quarantine restrictions causing some visits to be
conducted out of window, and short follow-up time.
Clinical efficacy was observed at 150 days; however, longer
follow-up can be helpful to assess longer-term efficacy.
Additional treatments could further improve efficacy.
Furthermore, an evaluation of specimens in the treatment
areas can help delineate the histological changes seen when
treatments are combined. Future studies are needed to
follow patients up for a longer period, to optimize settings
used, and to assess for the amount of collagen that is
produced through histology or ultrasound examination.
Neck Rejuvenation • Almukhtar et al

In conclusion, this is the first clinical trial to date to
compare efficacy and safety of nonablative 1,550-nm
erbium:glass laser and radiofrequency microneedling in
rejuvenation of the neck. This study showed that both
treatments resulted in significant improvement in wrinkling
and elastosis scores; the NAFL treatment was associated
with significantly better blinded investigator Fitzpatrick–
Goldman Wrinkling and Elastosis scores and better subject
satisfaction when compared with RFMN at Day 150. The
RFMN group showed more significant improvement of the
Horizontal Neck Wrinkle Severity Scores. There was
slightly less downtime for the NAFL group than the RFMN
group, but both lasers were well-tolerated.
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